BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 35313837)

  • 21. Implication for second primary cancer from visible oral and oropharyngeal premalignant lesions in betel-nut chewing related oral cancer.
    Liu SY; Feng IJ; Wu YW; Chen CY; Hsiung CN; Chang HW; Lin CY; Chang MT; Yu HC; Lee SY; Yen CY
    Head Neck; 2017 Jul; 39(7):1428-1435. PubMed ID: 28383824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of oral cancer associated with human papillomavirus infection, betel quid chewing, and cigarette smoking in Taiwan--an integrated molecular and epidemiological study of 58 cases.
    Chen PC; Kuo C; Pan CC; Chou MY
    J Oral Pathol Med; 2002 Jul; 31(6):317-22. PubMed ID: 12190813
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Usefulness of human papillomavirus detection in oral rinse as a biomarker of oropharyngeal cancer.
    Yoshida H; Murono S; Ueno T; Nakanishi Y; Tsuji A; Hatano M; Endo K; Kondo S; Sugimoto H; Wakisaka N; Yoshizaki T
    Acta Otolaryngol; 2017 Jul; 137(7):773-777. PubMed ID: 28093931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Circulating human papillomavirus DNA as a marker for disease extent and recurrence among patients with oropharyngeal cancer.
    Dahlstrom KR; Li G; Hussey CS; Vo JT; Wei Q; Zhao C; Sturgis EM
    Cancer; 2015 Oct; 121(19):3455-64. PubMed ID: 26094818
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detailed Analysis of Clinicopathologic Factors Demonstrate Distinct Difference in Outcome and Prognostic Factors Between Surgically Treated HPV-Positive and Negative Oropharyngeal Cancer.
    Iyer NG; Dogan S; Palmer F; Rahmati R; Nixon IJ; Lee N; Patel SG; Shah JP; Ganly I
    Ann Surg Oncol; 2015 Dec; 22(13):4411-21. PubMed ID: 25801358
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human papillomavirus prevalence and prognostic implication in oropharyngeal squamous cell carcinomas.
    Melkane AE; Auperin A; Saulnier P; Lacroix L; Vielh P; Casiraghi O; Msakni I; Drusch F; Temam S
    Head Neck; 2014 Feb; 36(2):257-65. PubMed ID: 23728782
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck Cancer.
    Buglione M; Maddalo M; Corvò R; Pirtoli L; Paiar F; Lastrucci L; Stefanacci M; Belgioia L; Crociani M; Vecchio S; Bonomo P; Bertocci S; Borghetti P; Pasinetti N; Triggiani L; Costa L; Tonoli S; Grisanti S; Magrini SM
    Int J Radiat Oncol Biol Phys; 2017 Mar; 97(3):462-472. PubMed ID: 27986347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prevalence of human papillomavirus in oropharyngeal cancer is increasing regardless of sex or race, and the influence of sex and race on survival is modified by human papillomavirus tumor status.
    Faraji F; Rettig EM; Tsai HL; El Asmar M; Fung N; Eisele DW; Fakhry C
    Cancer; 2019 Mar; 125(5):761-769. PubMed ID: 30521092
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Different protein expression associated with chemotherapy response in oropharyngeal cancer according to HPV status.
    Kim MJ; Ki MS; Kim K; Shim HJ; Hwang JE; Bae WK; Chung IJ; Lee DH; Lee JK; Yoon TM; Lim SC; Chung WK; Jeong JU; Lim HS; Choi YD; Cho SH
    BMC Cancer; 2014 Nov; 14():824. PubMed ID: 25380690
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The applicability of new TNM classification for humanpapilloma virus-related oropharyngeal cancer in the 8th edition of the AJCC/UICC TNM staging system in Japan: A single-centre study.
    Sano D; Yabuki K; Arai Y; Tanabe T; Chiba Y; Nishimura G; Takahashi H; Yamanaka S; Oridate N
    Auris Nasus Larynx; 2018 Jun; 45(3):558-565. PubMed ID: 28760331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EGFR overexpression and macrophage infiltration correlate with poorer prognosis in HPV-negative oropharyngeal cancer via STAT6 signaling.
    Lee HP; Li CJ; Lee CC
    Head Neck; 2024 Jun; 46(6):1294-1303. PubMed ID: 38497289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human papillomavirus in oropharyngeal squamous cell carcinoma in South-Eastern Norway: prevalence, genotype, and survival.
    Fossum GH; Lie AK; Jebsen P; Sandlie LE; Mork J
    Eur Arch Otorhinolaryngol; 2017 Nov; 274(11):4003-4010. PubMed ID: 28933005
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Betel nut chewing and related factors in adolescent students in Taiwan.
    Wang SC; Tsai CC; Huang ST; Hong YJ
    Public Health; 2003 Sep; 117(5):339-45. PubMed ID: 12909424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Staging and prognosis of oropharyngeal carcinoma according to the 8th Edition of the American Joint Committee on Cancer Staging Manual in human papillomavirus infection.
    Yamashita Y; Ikegami T; Hirakawa H; Uehara T; Deng Z; Agena S; Uezato J; Kondo S; Kiyuna A; Maeda H; Suzuki M; Ganaha A
    Eur Arch Otorhinolaryngol; 2019 Mar; 276(3):827-836. PubMed ID: 30594962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The emerging risk of oropharyngeal and oral cavity cancer in HPV-related subsites in young people in Brazil.
    Menezes FDS; Latorre MDRDO; Conceição GMS; Curado MP; Antunes JLF; Toporcov TN
    PLoS One; 2020; 15(5):e0232871. PubMed ID: 32407339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial.
    Posner MR; Lorch JH; Goloubeva O; Tan M; Schumaker LM; Sarlis NJ; Haddad RI; Cullen KJ
    Ann Oncol; 2011 May; 22(5):1071-1077. PubMed ID: 21317223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence of human papillomavirus-related oropharyngeal cancer and outcomes after chemoradiation in a population of heavy smokers.
    Cerezo L; López C; de la Torre A; Suárez D; Hervás A; Ruiz A; Ballestín C; Martín M; Sandoval P
    Head Neck; 2014 Jun; 36(6):782-6. PubMed ID: 23616290
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Confirmation of proposed human papillomavirus risk-adapted staging according to AJCC/UICC TNM criteria for positive oropharyngeal carcinomas.
    Horne ZD; Glaser SM; Vargo JA; Ferris RL; Balasubramani GK; Clump DA; Heron DE; Beriwal S
    Cancer; 2016 Jul; 122(13):2021-30. PubMed ID: 27111669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral cancer incidence rates from 1997 to 2016 among men in Taiwan: Association between birth cohort trends and betel nut consumption.
    Su SY; Chen WT; Chiang CJ; Yang YW; Lee WC
    Oral Oncol; 2020 Aug; 107():104798. PubMed ID: 32434121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oropharyngeal cancer - is it time to change management according to human papilloma virus status?
    Mehanna H; Olaleye O; Licitra L
    Curr Opin Otolaryngol Head Neck Surg; 2012 Apr; 20(2):120-4. PubMed ID: 22327790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.